
Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications
Author(s) -
May Y. Choi,
Daniel Li,
Candace H. Feldman,
Kazuki Yoshida,
Hongshu Guan,
Seoyoung Kim,
Brendan M. Everett,
Karen H. Costenbader
Publication year - 2020
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/keaa862
Subject(s) - medicine , hazard ratio , proportional hazards model , propensity score matching , confidence interval
SLE patients have elevated cardiovascular disease (CVD) risk, but it is unclear whether this risk is affected by choice of immunosuppressive drug. We compared CVD risks among SLE patients starting MMF, CYC or AZA.